Form 4 for COYA Coya Therapeutics, Inc.
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-13 · accession 0001493152-24-045120 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-13 | 2024-11-13 | COYA | Swaminathan Arun | CEO, Dir | P - Purchase | $7.36 | +5,000 | 10.0K | +100% | +$36.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2024-11-13 | P | A | 5,000 | $7.36 | 10,000 | D | — | — |